Dr. Edward Martin is an associate in the Corporate Department of Latham & Watkins' Hamburg office.

Dr. Martin mainly advises in the areas of mergers and acquisitions, private equity, and general corporate law. He represents both German and international companies and financial investors.

Dr. Martin studied in Hamburg, Berlin, and Paris.

Dr. Martin’s experience includes advising:

  • Apollo on a €1 billion investment in a portfolio of real estate assets controlled by Vonovia 
  • One Rock on the acquisition of Constantia Flexibles
  • IK Partners on a majority investment in Cinerius Financial Partners
  • Protective Industrial Products on the acquisition of ISM
  • CHEPLAPHARM on the acquisition of Zyprexa® from Eli Lilly and Company and on a €750 million bridge loan in connection with the acquisition
  • Antin Infrastructure Partners on the sale of its majority stake in amedes Group
  • Bitly on the acquisition of Egoditor
  • CHEPLAPHARM on the acquisition of a global medicinal product portfolio from Bristol-Myers Squibb
  • The founders of KMK Kinderzimmer Group on the sale of the majority shareholding to Franz Haniel & Cie
  • Körber on the sale of a minority stake in its supply chain software business to KKR
  • One Rock Capital Partners on the acquisition of Prefere Resins Group
  • Platinum Equity on the acquisition of Continental Bakeries

Bar Qualification

  • Rechtsanwalt (Germany)


  • Second German State Exam, Higher Regional Court, Hamburg
  • Dr. iur., University of Hamburg
  • First German State Exam, University of Hamburg